Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis

Condition:   Bacterial VaginosisInterventions:   Drug: 5% Monolaurin Vaginal Gel;   Other: PlaceboSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified March 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials